Table 4. Cox regression model for the outcome of the composite endpoint.
Measures | COVID-19 | Viral controls | Bacterial controls | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n = 191 | n = 227 | n = 96 | ||||||||||
Univariable | Multivariable | Univariable | Multivariable | Univariable | Multivariable | |||||||
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
IL-6 | 6.602 (3.113–14.003) | <0.001 | 6.602 (3.113–14.003) | <0.001 | 3.630 (1.602–8.227) | 0.002 | - | - | 2.277 (1.200–4.321) | 0.012 | 2.101 (1.042–4.239) | 0.038 |
CRP | 5.519 (2.187–13.932) | <0.001 | - | - | 7.651 (1.562–37.48) | 0.012 | 7.651 (1.562–37.480) | 0.012 | 2.484 (0.914–6.754) | 0.075 | 3.091 (0.839–11.393) | 0.090 |
PCT | 2.796 (1.476–5.297) | 0.002 | - | - | 3.445 (1.414–8.394) | 0.006 | - | - | 1.862 (1.064–3.258) | 0.029 | - | - |
Ferritin | 4.397 (1.632–11.845) | 0.003 | - | - | 0.927 (0.126–6.811) | 0.941 | - | - | 0.558 (0.215–1.449) | 0.231 | 0.290 (0.082–1.022) | 0.054 |
Leukocytes | 5.066 (0.834–30.771) | 0.078 | - | - | 10.899 (0.027–4377.491) | 0.435 | - | - | 0.710 (0.099–5.116) | 0.734 | - | - |
p-values for comparison of HR were calculated using the log-rank test
values were logarithmized to approach a normal distribution, values for the multivariable model were selected using a backwards selection process
HR = hazard ratio, CI = confidence interval, IL-6 = interleukin-6, CRP = c-reactive protein, PCT = procalcitonin.